financing
Neurogene Announces $200M PIPE Financing
The company will use the funds to enroll a registrational trial for its investigational gene therapy NGN-401 for Rett syndrome.
Pathos AI Closes $62M Series C Funding Round
The financing will allow the firm to further develop its AI platform, develop drugs in best responders, and acquire new pipeline candidates.
March Biosciences Raises $28.4M in Series A Financing
The firm will put the funds toward advancing its autologous CAR T-cell therapy MB-105 into Phase II clinical trials in CD5-positive lymphoma.
Immatics to Raise $150M in Public Stock Offering
The firm is developing T-cell receptor therapies for advanced solid tumors including metastatic melanoma.
Purespring Therapeutics Raises £80M in Series B Round to Launch Kidney Disease Gene Therapy Trial
The London-based firm said it will use the funds to advance its gene therapy pipeline, including its lead program in IgA nephropathy.
Sep 10, 2024
Ionis Pharmaceuticals Prices $500.3M Stock Offering
Aug 13, 2024
MeiraGTx Gets $30M Equity Investment From Sanofi
Jul 11, 2024